Cow slaughter ban, crime against women Eshwarappa’s main poll planks

coastaldigest.com news network
April 9, 2018

Shivamogga, Apr 9: K S Eshwarappa, the leader of Opposition in Legislative Council, has indirectly made it clear that development will not be his main plank in upcoming legislative elections.

The BJP has already issued B Form to Eshwarappa to contest May 12 Assembly polls from Shivamogga urban constituency. He is expected to file nomination on April 19

The former deputy chief minister told media persons on Monday that that (sensational) issues like cow slaughter ban and crime against women would be his main poll planks.

He dared Chief Minister Siddaramaiah to win Chamundeshwari seat first before talking of becoming chief minister again.

Comments

Kalimama
 - 
Tuesday, 10 Apr 2018

one of the shittest face i have ever seen in BJP. even animal face are better than these cowards.

 

do good to mankind first

 

Well Wisher
 - 
Monday, 9 Apr 2018

Stop the bullship Mr. Eshwarappa,

Forget about ban on cow slaughter. Why are you selling your mother to foreigners by exporting it. If you dare, stop beef export then talk about ban cow slaughter. Bloody coward.

CK Lobo
 - 
Monday, 9 Apr 2018

Rubbish. In fact we should call it poll pranks. Not planks. They just want sensational issues. They will surely turn Indian into Somalia.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 5,2020

Mangaluru, May 5: The Dakshina Kannada district administration has denotified two containment zones, Sampya in Puttur and Thumbe in Bantwal. They were declared containment zones after one coronavirus positive case was reported from each area.

All the primary and secondary contacts of the patients have completed home quarantine period, said DC Sindhu B Rupesh.

The district administration hitherto had already denotified three other such containment zones based on a report of DHO,  after no new case was reported in the area in the last 28 days.

At present, the district has six containment zones-- Shakthinagara, Boloor, First Neuro Hospital in Mangaluru city, Uppinangady in Puttur, Kasaba and Narikombu in Bantwal taluk.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 11,2020

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 2,2020

Bengaluru, Jul 2: Karnataka government has issued a show-cause notice to 18 private hospitals for refusing to admit a 52-year-old patient with influenza-like illness (ILI) symptoms, who later died.

According to the notice dated on June 30, a 52-years patient named Bhawarlal Sujani died after he was denied admission by 18 private hospitals.

The patient was taken to these hospitals on Saturday and Sunday for admission on observing some ILI like symptoms. But none of these hospitals admitted in on the pretext of unavailability of bed/ventilators, read the notice.

This is a clear violation of providing medical assistance and admission necessitated under the agreed provision of KPME Registration. They should strictly adhere to the provisions under Sections 11 & 11 A of KPME Act 2017. Private Medical Establishments cannot deny/ refuse/ avoid treatment to patients with Covid-19 and Covid-19 like symptoms, the state Health Department said.

By denying the admission to the deceased patient, your hospitals have violated the provisions of the above-said act. You are liable for legal action in this regard, as per the notice.

The state Health department asked the hospitals to reply as to why action should not be initiated under the relevant Acts. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.